Stay updated on Subcutaneous vs Intravenous Atezolizumab in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Subcutaneous vs Intravenous Atezolizumab in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Subcutaneous vs Intravenous Atezolizumab in NSCLC Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    New sections Adverse Events, Outcome Measures, Participant Flow, Contacts/Locations, and Study Status were added in versions dated 2025-11-23 and 2025-12-11; a prior entry dated 2024-11-21 was removed.
    Difference
    0.7%
    Check dated 2025-12-16T20:57:23.000Z thumbnail image
  2. Check
    7 days ago
    No Change Detected
  3. Check
    14 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    Revision from v3.2.0 to v3.3.2 is shown in the Record History, reflecting a system/UI update. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-25T11:24:19.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    Notice about government funding and operating status at the top of the page was removed; this appears to be a site-wide administrative update rather than a modification to the study record or its results. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2025-11-18T07:11:20.000Z thumbnail image
  6. Check
    43 days ago
    Change Detected
    Summary
    The new screenshot shows the same study record history and page sections as the old version, with only minor visual adjustments; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-03T21:04:16.000Z thumbnail image
  7. Check
    72 days ago
    Change Detected
    Summary
    Added a prominent operating-status notice and a v3.2.0 version tag, replacing the prior v3.1.0 revision.
    Difference
    10%
    Check dated 2025-10-06T05:47:25.000Z thumbnail image
  8. Check
    79 days ago
    Change Detected
    Summary
    Changed the revision from v3.0.2 to v3.1.0, indicating a minor version update with no substantive content changes.
    Difference
    0.3%
    Check dated 2025-09-29T03:09:19.000Z thumbnail image

Stay in the know with updates to Subcutaneous vs Intravenous Atezolizumab in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Subcutaneous vs Intravenous Atezolizumab in NSCLC Clinical Trial page.